Oncology: Genetic and Viral Origins of Cancer (Audio-Digest Foundation Oncology Continuing Medical Education (CME). Book 2)
This edition of this title is not available for purchase in your country. Choose an available edition from the options above
Book Details
Author(s)Digest, Audio
ISBN / ASINB008AWATAQ
ISBN-13978B008AWATA4
AvailabilityThis edition of this title is not available for purchase in your country. Choose an available edition from the options above
MarketplaceUnited States 🇺🇸
Description
Purpose: Audio-Digest Foundation CME/CE activities are designed to provide its learners – physicians and other healthcare professionals – with continuing education that will help identify clinical problems in their practice settings, provide content to help to solve those problems, and increase their application of knowledge to practice.
Audio-Digest Oncology is specifically designed to provide the participant with up-to-date and accurate information on areas of competency as identified by the ABIM Medical Oncology MOC Examination Blueprint and ASCO's Core Curriculum Outline. Topics include, but are not limited to, the following:
The 37 cancer types and sites
Treatment regimens and methods, including chemotherapy, radiation therapy, hormonal therapies, and biological response modifiers
Other treatment-related issues, including oncological emergencies, paraneoplastic syndrome, bone marrow transplantation, local therapy of metastatic cancers, and management of malignant effusions
Complications, including infections and other complications of treatment; effects of disease and treatment on the patient, including psychosocial and psychological issues
Supportive care, including pain management, hematopoietic growth factors, transfusion therapy,nutritional support, end-of-life care, etc.
Procedures, including chemotherapy administrations, tumor assessment, bone marrow aspiration, biopsy and interpretation
Geriatric oncology
The goal of this program is to improve management of cancer through increasing clinicians’ awareness of the latest findings about genetic and viral origins of cancer. After hearing and assimilating this program, the clinician will be better able to:
1: Explain genetic principles as they relate to the pathophysiology of cancer.
2: Identify gene pathways associated with transformation of normal cells to cancer cells.
3: Assess risk for cancer in patients who are carriers of BRCA1 and BRCA2 gene mutations.
4: Discuss the role of the Epstein-Barr virus (EBV) and Kaposi sarcoma herpesvirus (KSHV) in lymphogenesis.
5: List lymphomas and lymphoproliferative disorders associated with EBV and KSHV.
Audio-Digest Oncology is specifically designed to provide the participant with up-to-date and accurate information on areas of competency as identified by the ABIM Medical Oncology MOC Examination Blueprint and ASCO's Core Curriculum Outline. Topics include, but are not limited to, the following:
The 37 cancer types and sites
Treatment regimens and methods, including chemotherapy, radiation therapy, hormonal therapies, and biological response modifiers
Other treatment-related issues, including oncological emergencies, paraneoplastic syndrome, bone marrow transplantation, local therapy of metastatic cancers, and management of malignant effusions
Complications, including infections and other complications of treatment; effects of disease and treatment on the patient, including psychosocial and psychological issues
Supportive care, including pain management, hematopoietic growth factors, transfusion therapy,nutritional support, end-of-life care, etc.
Procedures, including chemotherapy administrations, tumor assessment, bone marrow aspiration, biopsy and interpretation
Geriatric oncology
The goal of this program is to improve management of cancer through increasing clinicians’ awareness of the latest findings about genetic and viral origins of cancer. After hearing and assimilating this program, the clinician will be better able to:
1: Explain genetic principles as they relate to the pathophysiology of cancer.
2: Identify gene pathways associated with transformation of normal cells to cancer cells.
3: Assess risk for cancer in patients who are carriers of BRCA1 and BRCA2 gene mutations.
4: Discuss the role of the Epstein-Barr virus (EBV) and Kaposi sarcoma herpesvirus (KSHV) in lymphogenesis.
5: List lymphomas and lymphoproliferative disorders associated with EBV and KSHV.
